Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.

Integration Core

Authors Hansoo Park, Sung-Yup Cho, Hyerim Kim, Deukchae Na, Jee Yun Han, Jeesoo Chae, Changho Park, Ok-Kyoung Park, Seoyeon Min, Jinjoo Kang, Boram Choi, Jimin Min, Jee Young Kwon, Yun-Suhk Suh, Seong-Ho Kong, Hyuk-Joon Lee, Edison T. Liu, Jong-Il Kim, Sunghoon Kim, Han-Kwang Yang, Charles Lee
Journal Proceedings of the National Academy of Sciences of the United States of America
Vol.(no.) 112(40)
Pages 12492-12497
Year 20151006
DOI http://10.1073/pnas.1507491112
Attach 20151006_PNAS_112(40)_12492-12497.pdf


Related Post

A new targeting drug got published in Nature.
views 463
Halofuginone was used in a clinical trial for cancer and fibrotic diseases.  It was found to bind to tRNA and it targets the active site of ...
An article about Drug repositioning utilizing Phar...
views 770
The article about Drug repositioning using the medicine data based PharmDB, which is built by Biocon, i-Pharm, and KOBIC got an approval to be publish...
Call For Papers – 2012 Workshop on Pharmaco-...
views 456
Call For Papers - 2012 Workshop on Pharmaco-Informatics for Drug DiscoveryPhiladelphia, USAOctober 4-7, 2012

Leave a reply

Your email address will not be published. Required fields are marked *



We're not around right now. But you can send us an email and we'll get back to you, asap.


©2010-2019 Medicinal Bioconvergence Research Center. All rights reserved.

Log in with your credentials

Forgot your details?

Skip to toolbar